CRISM Therapeutics (CRTX) Competitors GBX 21.76 +5.26 (+31.88%) As of 05/2/2025 11:22 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsBuy This Stock CRTX vs. CTL, GROC, KDNC, BHL, ATN, JAY, PYX, BMV, AYM, and BZTShould you be buying CRISM Therapeutics stock or one of its competitors? The main competitors of CRISM Therapeutics include CleanTech Lithium (CTL), GreenRoc Mining (GROC), Cadence Minerals (KDNC), Bradda Head Lithium (BHL), Aterian (ATN), Bluejay Mining (JAY), PYX Resources (PYX), Bluebird Merchant Ventures (BMV), Anglesey Mining (AYM), and Bezant Resources (BZT). These companies are all part of the "other industrial metals & mining" industry. CRISM Therapeutics vs. CleanTech Lithium GreenRoc Mining Cadence Minerals Bradda Head Lithium Aterian Bluejay Mining PYX Resources Bluebird Merchant Ventures Anglesey Mining Bezant Resources CleanTech Lithium (LON:CTL) and CRISM Therapeutics (LON:CRTX) are both small-cap basic materials companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, dividends, valuation, earnings, institutional ownership, risk, analyst recommendations, profitability and community ranking. Does the media favor CTL or CRTX? In the previous week, CleanTech Lithium's average media sentiment score of 0.00 equaled CRISM Therapeutics'average media sentiment score. Company Overall Sentiment CleanTech Lithium Neutral CRISM Therapeutics Neutral Which has preferable earnings and valuation, CTL or CRTX? CRISM Therapeutics is trading at a lower price-to-earnings ratio than CleanTech Lithium, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCleanTech LithiumN/AN/A-£2.19M-£2.87-2.75CRISM TherapeuticsN/AN/A-£792.20K-£5.81-3.74 Is CTL or CRTX more profitable? CRISM Therapeutics' return on equity of -13.12% beat CleanTech Lithium's return on equity.Company Net Margins Return on Equity Return on Assets CleanTech LithiumN/A -22.14% -13.50% CRISM Therapeutics N/A -13.12%-26.77% Do insiders & institutionals believe in CTL or CRTX? 16.8% of CleanTech Lithium shares are owned by institutional investors. 12.5% of CleanTech Lithium shares are owned by company insiders. Comparatively, 68.8% of CRISM Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Which has more volatility & risk, CTL or CRTX? CleanTech Lithium has a beta of -0.79, suggesting that its share price is 179% less volatile than the S&P 500. Comparatively, CRISM Therapeutics has a beta of 0.81, suggesting that its share price is 19% less volatile than the S&P 500. Does the MarketBeat Community believe in CTL or CRTX? CleanTech Lithium received 3 more outperform votes than CRISM Therapeutics when rated by MarketBeat users. CompanyUnderperformOutperformCleanTech LithiumOutperform Votes3100.00% Underperform VotesNo VotesCRISM TherapeuticsN/AN/A SummaryCleanTech Lithium beats CRISM Therapeutics on 5 of the 9 factors compared between the two stocks. Get CRISM Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRTX vs. The Competition Export to ExcelMetricCRISM TherapeuticsOther Industrial Metals & Mining IndustryMaterials SectorLON ExchangeMarket Cap£2.37M£995.57M£3.06B£2.65BDividend YieldN/A6.22%5.20%4.82%P/E Ratio-3.7441.1675.64134.53Price / SalesN/A20,448.9924,391,232,012,628,000.00243,908.30Price / CashN/A25.2124.3728.40Price / Book0.517.485.314.53Net Income-£792,204.93£70.70M£155.40M£5.92B7 Day Performance104.90%2.18%0.59%3.28%1 Month Performance172.00%14.14%9.81%8.75%1 Year PerformanceN/A44.02%17.94%26.51% CRISM Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRTXCRISM TherapeuticsN/AGBX 21.76+31.9%N/AN/A£2.37MN/A-3.744Gap DownHigh Trading VolumeCTLCleanTech LithiumN/AGBX 7.50-9.1%N/A-63.0%£5.91MN/A-2.6220GROCGreenRoc MiningN/AGBX 2.97-1.0%N/A+38.1%£5.74MN/A-3.856Gap UpKDNCCadence MineralsN/AGBX 1.90-5.1%N/A-48.4%£5.50MN/A-0.966Gap DownBHLBradda Head LithiumN/AGBX 1.05+4.8%N/A-31.7%£5.12MN/A1.76N/AGap DownHigh Trading VolumeATNAterianN/AGBX 41.50flatN/A+6,130.8%£5.00MN/A-2,214.5722Earnings ReportJAYBluejay MiningN/AN/AN/AN/A£4.98M£-1,048.00-12.5813Gap UpHigh Trading VolumePYXPYX ResourcesN/AN/AN/AN/A£4.69M£21.97M-2.3195Gap DownBMVBluebird Merchant VenturesN/AGBX 0.65+8.3%N/A+0.2%£4.63MN/A215.009Earnings ReportPositive NewsGap DownAYMAnglesey MiningN/AGBX 0.90+5.9%N/A-35.7%£4.59MN/A-0.012Gap DownHigh Trading VolumeBZTBezant ResourcesN/AGBX 0.03flatN/A+25.0%£4.45MN/A-534.355 Related Companies and Tools Related Companies CleanTech Lithium Alternatives GreenRoc Mining Alternatives Cadence Minerals Alternatives Bradda Head Lithium Alternatives Aterian Alternatives Bluejay Mining Alternatives PYX Resources Alternatives Bluebird Merchant Ventures Alternatives Anglesey Mining Alternatives Bezant Resources Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:CRTX) was last updated on 5/5/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredMan who predicted $100K Bitcoin sees a huge run coming for another coin …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CRISM Therapeutics Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share CRISM Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CRTX Stock Free CRTX Stock Alerts